<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2023.1250719</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>SpiB regulates the expression of B-cell-related genes and increases the longevity of memory B cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Horiuchi</surname>
<given-names>Shu</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/83896"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Koike</surname>
<given-names>Takuya</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2385027"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Takebuchi</surname>
<given-names>Hirofumi</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2363739"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hoshino</surname>
<given-names>Katsuaki</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sasaki</surname>
<given-names>Izumi</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Fukuda-Ohta</surname>
<given-names>Yuri</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kaisho</surname>
<given-names>Tsuneyasu</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/435253"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kitamura</surname>
<given-names>Daisuke</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/83902"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Division of Cancer Cell Biology, Research Institute for Biomedical Sciences, Tokyo University of Science</institution>, <addr-line>Noda, Chiba</addr-line>, <country>Japan</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Immunology, Faculty of Medicine, Kagawa University</institution>, <addr-line>Miki-cho, Kagawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>Laboratory for Human Disease Models, RIKEN Center for Integrative Medical Sciences</institution>, <addr-line>Yokohama, Kanagawa</addr-line>, <country>Japan</country>
</aff>
<aff id="aff4">
<sup>4</sup>
<institution>Department of Immunology, Institute of Advanced Medicine, Wakayama Medical University</institution>, <addr-line>Wakayama</addr-line>, <country>Japan</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Rinako Nakagawa, The Francis Crick Institute, United Kingdom</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Mauro Gaya, INSERM U1104 Centre d&#x2019;immunologie de Marseille-Luminy (CIML), France; Stephen Nutt, The University of Melbourne, Australia</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Daisuke Kitamura, <email xlink:href="mailto:kitamura@rs.tus.ac.jp">kitamura@rs.tus.ac.jp</email>
</p>
</fn>
<fn fn-type="present-address" id="fn003">
<p>&#x2020;Present addresses: Shu Horiuchi, CSL, Waltham, MA, United States; Takuya Koike, Center for Infectious Disease Education and Research, Osaka University, Osaka, Japan</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>27</day>
<month>10</month>
<year>2023</year>
</pub-date>
<pub-date pub-type="collection">
<year>2023</year>
</pub-date>
<volume>14</volume>
<elocation-id>1250719</elocation-id>
<history>
<date date-type="received">
<day>30</day>
<month>06</month>
<year>2023</year>
</date>
<date date-type="accepted">
<day>18</day>
<month>09</month>
<year>2023</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2023 Horiuchi, Koike, Takebuchi, Hoshino, Sasaki, Fukuda-Ohta, Kaisho and Kitamura</copyright-statement>
<copyright-year>2023</copyright-year>
<copyright-holder>Horiuchi, Koike, Takebuchi, Hoshino, Sasaki, Fukuda-Ohta, Kaisho and Kitamura</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Generation of memory B cells is one of the key features of adaptive immunity as they respond rapidly to re-exposure to the antigen and generate functional antibodies. Although the functions of memory B cells are becoming clearer, the regulation of memory B cell generation and maintenance is still not well understood. Here we found that transcription factor SpiB is expressed in some germinal center (GC) B cells and memory B cells and participates in the maintenance of memory B cells. Overexpression and knockdown analyses revealed that SpiB suppresses plasma cell differentiation by suppressing the expression of Blimp1 while inducing Bach2 in the <italic>in-vitro</italic>-induced germinal center B (iGB) cell culture system, and that SpiB facilitates <italic>in-vivo</italic> appearance of memory-like B cells derived from the iGB cells. Further analysis in IgG1<sup>+</sup> cell-specific SpiB conditional knockout (cKO) mice showed that function of SpiB is critical for the generation of late memory B cells but not early memory B cells or GC B cells. Gene expression analysis suggested that SpiB-dependent suppression of plasma cell differentiation is independent of the expression of Bach2. We further revealed that SpiB upregulates anti-apoptosis and autophagy genes to control the survival of memory B cells. These findings indicate the function of SpiB in the generation of long-lasting memory B cells to maintain humoral memory.</p>
</abstract>
<kwd-group>
<kwd>memory B cell</kwd>
<kwd>germinal center B cell</kwd>
<kwd>SpiB</kwd>
<kwd>apoptosis</kwd>
<kwd>autophagy</kwd>
<kwd>humoral immune response</kwd>
<kwd>SpiB conditional knockout mice</kwd>
</kwd-group>
<contract-sponsor id="cn001">Ministry of Education, Culture, Sports, Science and Technology<named-content content-type="fundref-id">10.13039/501100001700</named-content>
</contract-sponsor>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="53"/>
<page-count count="12"/>
<word-count count="6715"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>B Cell Biology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Highlights</title>
<list list-type="order">
<list-item>
<p>GC and memory B cells express SpiB and SpiB expression is induced by CD40 stimulation <italic>in vitro</italic>.</p>
</list-item>
<list-item>
<p>SpiB suppresses plasma cell differentiation while inducing the expression of Bach2 <italic>in vitro</italic>.</p>
</list-item>
<list-item>
<p>SpiB overexpression enhances and SpiB knockdown diminishes B<sub>mem</sub>-like cell generation.</p>
</list-item>
<list-item>
<p>SpiB C&#x3b3;1-cKO mice generates less IgG1<sup>+</sup> late B<sub>mem</sub> cells with diminished memory antibody response.</p>
</list-item>
<list-item>
<p>SpiB suppresses plasma cell differentiation independent of Bach2.</p>
</list-item>
<list-item>
<p>SpiB C&#x3b3;1-cKO B cells express lower levels of anti-apoptosis and autophagy genes with less ability to survive.</p>
</list-item>
</list>
</sec>
<sec id="s2" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Upon immunization with T-cell-dependent (TD) antigens, antigen-activated B cells undergo proliferation and class switching of their B cell receptor (BCR) and differentiate into effector B cell populations. Some B cells differentiate to short-lived plasma cells (PCs) that produce low affinity antibodies at the early stage of the immune response. Other B cells differentiate to germinal center (GC) B cells to form GCs. In GCs, B cells undergo somatic hypermutation (SHM) in variable regions of immunoglobulin genes, encoding BCR and antibodies, and selection based on the affinity of the resultant BCR to the antigen. Among the selected B cells, those expressing BCR with relatively higher affinity differentiate into long-lived PCs (LLPCs) whereas those with relatively lower affinity to memory B (B<sub>mem</sub>) cells. In addition, B<sub>mem</sub> cells are also generated independently of GCs. LLPCs and B<sub>mem</sub> cells, of either GC-experienced or not, contribute to long-term humoral immunity (<xref ref-type="bibr" rid="B1">1</xref>&#x2013;<xref ref-type="bibr" rid="B3">3</xref>).</p>
<p>B<sub>mem</sub> cells are maintained in the body for a long time and activated rapidly when re-exposed to the primary antigen, partly owing to IL-9 autocrine stimulation (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B5">5</xref>). The typical recall response for class-switched B<sub>mem</sub> cells is to produce a large amount of antigen-specific antibodies in a short time. A small proportion of the class-switched B<sub>mem</sub> cells and most IgM<sup>+</sup> B<sub>mem</sub> cells differentiate to GC B cells to undergo further SHM and affinity maturation during the recall response. Although regulatory mechanisms of the B<sub>mem</sub> cell recall response through BCR and other receptors are becoming clearer (<xref ref-type="bibr" rid="B4">4</xref>), the mechanisms for B<sub>mem</sub> cell development, including external signals and transcription factors that induce differentiation to B<sub>mem</sub> cells, are largely unknown. Bach2 is a transcriptional suppressor that regulates the expression of <italic>Blimp1</italic>, a gene encoding a transcription factor known to induce PC development. Bach2 was shown to be required for GC B-cell differentiation toward B<sub>mem</sub> cells albeit in a specific genetic background, namely Blimp1-deficiency (<xref ref-type="bibr" rid="B6">6</xref>).</p>
<p>To elucidate the mechanisms for B<sub>mem</sub> cell development, we established an experimental system in which naive B cells can be committed to either B<sub>mem</sub> cells or PCs <italic>in vitro</italic>. In this system, na&#xef;ve B cells are propagated on the feeder cells expressing exogenous CD40L and BAFF (termed 40LB) in the presence of IL-4 for the first 4-5 days. This culture allows massive expansion of B cells expressing GC B-cell markers, which we call &#x2018;induced GC B (iGB)-4 cells&#x2019;, and efficient class switching either to IgG1 or IgE. The following culture with IL-21 allows further proliferation of iGB cells (now called iGB-21) for another 4-5 days, gradually increasing the proportion of CD138<sup>+</sup> plasmablasts. Importantly, when transferred into irradiated wild type mice, the iGB-4 cells differentiate into memory-like B cells termed &#x201c;induced memory B (iMB) cells&#x201d;, which are phenotypically and functionally equivalent to <italic>bona fide</italic> B<sub>mem</sub> cells and survive more than 2 months in the spleens and lymph nodes of the recipient mice. Notably, IgG1<sup>+</sup> and IgM<sup>+</sup>, but not IgE<sup>+</sup>, iGB-4 cells become iMB cells <italic>in vivo</italic>. In contrast, iGB-21 cells fail to develop into iMB cells but instead differentiate into PCs in the bone marrow of the recipients. The iGB cells tertiary cultured for another 2 days without any cytokines (iGB-m) partly regain the ability to form iMB cells <italic>in vivo</italic> (<xref ref-type="bibr" rid="B7">7</xref>). From the data set of microarray analysis comparing iMB cells and naive follicular B cells, we selected the genes expressed in excess in iMB cells, and further selected those expressed at a higher level in IgG1<sup>+</sup> iGB-4 cells than in IgG1<sup>+</sup> iGB-21 cells, and not in IgE<sup>+</sup> iGB-4/iGB-21 cells, aiming to identify the genes that regulate B<sub>mem</sub> cell development. Among the genes selected in this approach, we focused on <italic>SpiB.</italic>
</p>
<p>SpiB is an ETS family transcription factor expressed in various types of immune cells (<xref ref-type="bibr" rid="B8">8</xref>&#x2013;<xref ref-type="bibr" rid="B10">10</xref>). In B cells, it has been reported to regulate the differentiation of pre-B cells in the bone marrow and follicular B cells (<xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B12">12</xref>). SpiB is also required for proper BCR signaling (<xref ref-type="bibr" rid="B13">13</xref>) and mature B cell survival, although being compensated by PU.1 (<xref ref-type="bibr" rid="B12">12</xref>), and for sustaining GC B cells in the primary, and antibody production in the secondary, TD immune response (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). In an <italic>in vitro</italic> study, SpiB suppresses PC differentiation in human and mice (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>). However, the role of SpiB in B cells after the generation of the GC is unknown.</p>
<p>Here we show our finding that SpiB is critical for B<sub>mem</sub> cell maintenance. <italic>SpiB</italic> mRNA is expressed in GC B cells and B<sub>mem</sub> cells, and its expression is upregulated by CD40 stimulation. Overexpression and knockdown of SpiB in iGB cells revealed that SpiB induces the expression of <italic>Bach2</italic> and suppresses the induction of <italic>Blimp1</italic> expression and the differentiation of CD138<sup>+</sup> PCs, independently of Bach2, and that SpiB facilitates iMB cell formation from iGB-4 cells <italic>in vivo</italic>. A conditional mouse strain that lacked SpiB only in IgG1<sup>+</sup> B cells (SpiB cKO) exhibited defective formation of IgG1<sup>+</sup> late B<sub>mem</sub> cells after primary immunization and attenuated IgG1 recall responses upon the secondary challenge. Additionally, B<sub>mem</sub> cells in the SpiB cKO mice showed lower expression of genes required for anti-apoptosis and autophagy, suggesting that SpiB is critical for long-term survival of B<sub>mem</sub> cells.</p>
</sec>
<sec id="s3" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s3_1">
<label>2.1</label>
<title>Mice and immunization</title>
<p>C57BL/6 NCrSlc (B6) mice were purchased from Sankyo Labo Service. All the following mouse strains were backcrossed to B6 or congenic B6 CD45.1<sup>+</sup> mice: <italic>SpiB</italic>
<sup>f/f</sup> (see below), <italic>Blimp1</italic>
<sup>f/f</sup>, Blimp1-GFP (<xref ref-type="bibr" rid="B18">18</xref>), and <italic>Bach2</italic>
<sup>-/-</sup> (<xref ref-type="bibr" rid="B19">19</xref>). <italic>SpiB</italic>
<sup>f/f</sup> and <italic>Blimp1</italic>
<sup>f/f</sup> mice were crossed with C&#x3b3;1-cre (<xref ref-type="bibr" rid="B20">20</xref>) and CD19-cre mice (<xref ref-type="bibr" rid="B21">21</xref>), respectively, to generate each conditional knockout strain. As the control for the <italic>SpiB</italic>
<sup>f/f</sup> C&#x3b3;1-cre (here called &#x2018;SpiB cKO&#x2019;) mice, <italic>SpiB</italic>
<sup>+/+</sup> C&#x3b3;1-cre (here called &#x2018;SpiB WT&#x2019;) mice were used. Sex-matched 7-12 week-old mice were immunized i.p. with 100 &#x3bc;g of 4-hydroxy-3-nitrophenyl acetyl (NP)<sub>32</sub>-chicken gamma globulin (CGG) in alum or NP-conjugated sheep red blood cell (SRBC) where indicated. Mice were maintained in the Tokyo University of Science mouse facility under specific pathogen-free conditions. Mouse procedures were performed under protocols approved by the Animal Care and Use Committee of Tokyo University of Science (Approval No S13009).</p>
</sec>
<sec id="s3_2">
<label>2.2</label>
<title>Generation of Spib-floxed mice</title>
<p>To generate the <italic>Spib</italic>-floxed (<italic>SpiB</italic>
<sup>f/f</sup>) mice, a targeting vector was designed to delete exon 6 encoding the Ets domain of Spi-B. To construct the targeting vector, C57BL/6N mouse genomic DNA fragments were amplified by PCR using KOD -plus- DNA polymerase (Toyobo, Osaka, Japan). An 8.0 kbp long arm containing exon 6, which has an insertion of a loxP site in the intron downstream of the exon 6, was connected to an MC1 promoter-driven neomycin resistance gene (neo) cassette flanked by two FRT sites and a loxP site. Then, a 1.9 kbp short arm containing exons 3-5 was ligated upstream of the neo cassette. A herpes simplex virus thymidine kinase gene (HSV-TK) was attached at the downstream end of the long arm. The targeting vector was linearized with SalI and electroporated into the Bruce4 ES cells. Clones with resistance to G418 and gancyclovir were screened for homologous recombination by PCR and confirmed by Southern blot analysis. ES cell clones carrying the targeted allele were used to generate <italic>Spib</italic> mutant mice. To delete the neo cassette flanked by two FRT sites, the <italic>Spib</italic>-targeted mice were intercrossed with C57BL/6-Tg(CAG-flpe)36Ito/ItoRbrc (RBRC01834) (RIKEN BioResource Research Center, Japan) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;1A</bold>
</xref>).</p>
<p>Genotyping of <italic>Spib</italic> mutant mice was performed by PCR using the primers listed below. PCR using primers #1 and #2 generates 301bp and 475 bp bands in the wild-type and floxed alleles, respectively. PCR using primers #1 and #3 generates a 454 bp band in the deleted allele. Although PCR using primers #1 and #3 should also generate a band with larger than 2700 bp in both wild-type and floxed alleles, it was too large to be detected (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;1B, C</bold>
</xref>).</p>
<p>Primer #1: 5&#x2019;-AACCAGGCCCAACTCCATTGTGAAAAC-3&#x2019;.</p>
<p>Primer #2: 5&#x2019;-GCCAGCTTCTGATACGTCATGCGCTTG-3&#x2019;.</p>
<p>Primer #3: 5&#x2019;-AGTCCTGTCACACCATTGGTTGCAGTG-3&#x2019;.</p>
</sec>
<sec id="s3_3">
<label>2.3</label>
<title>Flow cytometry</title>
<p>Single-cell suspensions from spleens were depleted of RBCs by ammonium chloride lysis, incubated with mAb to Fc&#x3b3;RII/III (2.4G2; BD Pharmingen) to block Fc&#x3b3;Rs and were stained for 30&#x2009;min on ice in PBS containing 0.5% BSA, 2&#x2009;mM EDTA, 0.05% sodium azide with various combinations of antibodies and reagents. Intracellular SpiB staining was performed with FoxP3 Staining Buffer Set according to the manufacturer&#x2019;s protocol (eBioscience) with anti-SpiB sheep polyclonal antibody (R&amp;D systems, AF7204) followed by Alexa 647-labeled donkey anti-sheep IgG (Invitrogen, A-21448). All samples were analyzed by either FACS Callibur or FACS Canto II (BD Biosciences). The data were analyzed by FlowJo (Tree Star).</p>
</sec>
<sec id="s3_4">
<label>2.4</label>
<title>Cell culture and purification</title>
<p>Splenic na&#xef;ve B cells were purified as described previously (<xref ref-type="bibr" rid="B7">7</xref>). B cells were cultured in RPMI-1640 medium (Wako) supplemented with 10% FCS, 10 mM HEPES, 1 mM sodium pyruvate, 5.5 &#xd7; 10<sup>&#x2212;5</sup> M 2-ME, 100 U/ml penicillin, and 100 &#x3bc;g/ml streptomycin (GIBCO). For iGB cell culture, naive B cells were cultured on 40LB feeder cells with IL-4 (10&#x2009;ng/ml) or IL-21 (10&#x2009;ng/ml) where indicated. To purify iGB cells or to change the culture condition, 40LB feeder cells were removed from the total cells of iGB cultures by anti-H-2Kd (BioLegend) Ab, Streptavidin Particle Plus DM and the IMag system (BD Biosciences).</p>
</sec>
<sec id="s3_5">
<label>2.5</label>
<title>Cell sorting</title>
<p>Early B<sub>mem</sub> and GC B cells were purified from spleen of the mice immunized with NP-SRBC, 7 or 14 days previously, as follows: splenocytes were stained with anti-CD19, anti-CD38, anti-GL7, and NP-BSA-biotin, followed by fluorescence-labeled streptavidin. B<sub>mem</sub> cells (CD19<sup>+</sup> NP<sup>+</sup> CD38<sup>+</sup> GL7<sup>&#x2013;</sup>) and GC B cells (CD19<sup>+</sup> NP<sup>+</sup> CD38<sup>&#x2013;</sup> GL7<sup>+</sup>) were sorted by FACS AriaII. For iGB cells, cultured cells depleted of 40LB feeder cells as described above, were stained with anti-IgG and anti-IgE and sorted by FACS Aria II.</p>
</sec>
<sec id="s3_6">
<label>2.6</label>
<title>Retroviral transduction</title>
<p>Retroviruses were produced in Plat-E cells transfected with pMXs-based vectors with Fugene HD (Promega) or PEI &#x201c;Max&#x201d; (Mw 40,000; Polysciences). The virus-containing supernatant was collected 2 days after transfection and added to iGB cells cultured for 2 days previously. Cells were spin-infected at 2,000 rpm, room temperature for 90 minutes with 10 &#x3bc;g/ml DOTAP Liposomal Transfection Reagent (Roche) and IL-4 (10 ng/ml). One day later, cells were collected and cultured on new 40LB feeder layers with IL-4 for further culture.</p>
</sec>
<sec id="s3_7">
<label>2.7</label>
<title>Adoptive transfer for iMB cell generation</title>
<p>iMB cells were generated as previously described (<xref ref-type="bibr" rid="B7">7</xref>). Retrovirally transduced iGB cells from CD45.1<sup>+</sup> B6 mice were collected by removing 40LB feeder cells with anti-H-2Kd Ab (BioLegend), Streptavidin Particle Plus DM, and the IMag system (BD Biosciences). The iGB cells were adoptively transferred to &#x3b3;-irradiated (6.5Gy) B6 mice (CD45.2<sup>+</sup>). Splenocytes were harvested from the recipient mice after 2 weeks or later for further analysis.</p>
</sec>
<sec id="s3_8">
<label>2.8</label>
<title>Quantitative RT-PCR</title>
<p>The procedures for RNA extraction and reverse transcription to cDNA have been described previously (<xref ref-type="bibr" rid="B7">7</xref>). Quantitative real-time PCR was performed with a 7500 fast Real-time PCR system (Applied Biosystems). Gene expression levels were determined by the relative standard curve method and normalized to that of either <italic>Gapdh</italic> or <italic>18S rRNA</italic>.</p>
</sec>
<sec id="s3_9">
<label>2.9</label>
<title>ELISA</title>
<p>Total and high affinity NP-specific IgG1 was detected by the method described previously (<xref ref-type="bibr" rid="B7">7</xref>). NP<sub>13.6</sub>-BSA or NP<sub>2.7</sub>-BSA for total or high affinity antibodies, respectively, was coated on 96 well flat bottom plate. Bound Abs were detected by HRP-conjugated goat anti-mouse IgG1 Ab (Southern Biotechnology) and TMB substrate (Sigma).</p>
</sec>
</sec>
<sec id="s4" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s4_1">
<label>3.1</label>
<title>GC and memory B cells express SpiB and SpiB expression is induced by CD40 stimulation <italic>in vitro</italic>
</title>
<p>To understand the regulation of B<sub>mem</sub> cells by transcription factors, we analyzed the gene-expression profiles of induced memory-like B (iMB) cells and compared the result with publicly available gene expression data (ImmGen). We noticed that mRNA for the transcription factor SpiB was expressed selectively high in B<sub>mem</sub> cells among B cells, while hardly expressed in plasmablasts and PCs. In contrast, Bcl6 was expressed substantially lower in B<sub>mem</sub> cells than in GC B cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;2A</bold>
</xref>). To confirm these expression patterns, we analyzed the mRNA levels of <italic>SpiB</italic>, <italic>Bach2</italic> and <italic>Bcl6</italic> in early B<sub>mem</sub> and GC B cells from mice immunized with NP-CGG, and na&#xef;ve follicular B cells from unimmunized mice. In slight contrast to the ImmGen data, <italic>SpiB</italic> expression in the early B<sub>mem</sub> cells was lower than that in GC B cells, but appeared to be higher than that in follicular B cells. These expression patterns are similar to those of <italic>Bach2</italic> and <italic>Bcl6</italic> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2B, C</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>SpiB is expressed in GC B and B<sub>mem</sub> cells and induced by CD40 stimulation <italic>in vitro.</italic> <bold>(A)</bold> <italic>SpiB</italic> mRNA expression in B cell subsets from mouse spleen collected 14 days post NP-CGG immunization. B cells were sorted as CD19<sup>+</sup> Ig&#x3ba;<sup>-</sup> and NP<sup>+</sup> CD38<sup>+</sup> GL7<sup>-</sup> (early B<sub>mem</sub> cells), NP<sup>+</sup> CD38<sup>-</sup>GL7<sup>+</sup> (GC B cells), or CD19<sup>+</sup> CD21<sup>lo</sup> CD23<sup>hi</sup> AA4.1<sup>-</sup> [naive follicular B (FoB) cells]. Comparison of early B<sub>mem</sub> and GC B cells (top) and na&#xef;ve FoB and GC B cells (bottom) are shown. <bold>(B)</bold> <italic>SpiB</italic> mRNA expression in B cells cultured on 40LB feeder cells for 0-3 days (left) and B cells stimulated with the indicated antibodies or LPS (right). <bold>(C)</bold> Immunofluorescence microscopy of frozen sections of spleens from mice immunized with NP-SRBC 7 days previously. The sections were stained for SpiB (blue), IgD (red), and Thy1.2 (green) (top), or for SpiB (blue) and B220 (red) (bottom). <bold>(D)</bold> <italic>SpiB</italic> mRNA expression in sorted IgG1<sup>+</sup> and IgE<sup>+</sup> from iGB cells cultured with IL-4 (iGB-4) for 4 days and IL-21 (iGB-21) for the following 4 days. <bold>(E)</bold> FCM analysis of the expression of CD138 and CD38 in SpiB<sup>high</sup> (blue) and SpiB<sup>low</sup> (red) iGB-4 and iGB-21 cells. SpiB staining profile and gating of iGB-4 and iGB-21 cells are shown on the left and the expression of CD138 and CD38 on the gated fractions are on the right. **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g001.tif"/>
</fig>
<p>Our previous finding proposed that the quantity of CD40 stimulation on B cells during the primary response is a key factor in regulating B<sub>mem</sub> cells (<xref ref-type="bibr" rid="B22">22</xref>). Additionally, SpiB is reported to be induced by OBF-1 which is upregulated by CD40 signaling (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Thus, we assessed whether CD40 stimulation induces the expression of <italic>SpiB</italic> in B cells. By culturing na&#xef;ve B cells on feeder cells expressing CD40L and BAFF (40LB) without any cytokines, the expression of <italic>SpiB</italic> was induced after 3 days (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). We then tested other stimuli known to activate na&#xef;ve B cells, namely, anti-CD40 or/and anti-IgM antibodies, or LPS, and observed that anti-CD40 induced the highest levels of <italic>SpiB</italic> expression among these stimuli, and no synergistic effect was seen between anti-CD40 and anti-IgM antibodies (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). These results indicate that CD40 stimulation is sufficient to induce SpiB expression in B cells. Immunofluorescence microscopy analysis of spleens from mice immunized with NP-SRBC 7 days earlier showed that a small number of discernible SpiB<sup>+</sup> cells were scattered in GC, B cell follicles, and T cell zones in the white pulp, while SpiB expression was undetectable in the vast majority of GC and follicular B cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, top). At a closer look, nuclear SpiB<sup>+</sup> cells in the B cell follicle were also B220<sup>+</sup> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1C</bold>
</xref>, bottom), either IgD<sup>+</sup> or IgD<sup>&#x2013;</sup>, and those in the GC and T cell zones were discernible as IgD<sup>&#x2013;</sup> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>, top). Together with our mRNA expression data and previous reports showing that <italic>SpiB</italic> mRNA expression is limited to B cells and plasmacytoid dendritic cells (9; ImmGen), these results suggest that a significant level of SpiB is expressed in selected GC B cells, class-switched or unswitched B<sub>mem</sub> cells in the B cell follicle, and plasmacytoid dendritic cells in the T cell zone.</p>
<p>It has been shown that SpiB suppresses the expression of Blimp1 in human cells (<xref ref-type="bibr" rid="B17">17</xref>) and potentially in mice (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B25">25</xref>). To further infer the role of SpiB in the late B-cell development, we analyzed the expression of SpiB in B cells cultured in the iGB system (<xref ref-type="bibr" rid="B7">7</xref>). The expression of <italic>SpiB</italic> mRNA was readily detected in IgG1<sup>+</sup> B cells cultured on 40LB feeder cells with IL-4 (iGB-4 cells), and in IgE<sup>+</sup> iGB-4 cells albeit at a reduced level, but declined to an almost undetectable level following culture with IL-21 (iGB-21 cells) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1D</bold>
</xref>). SpiB protein expression was also decreased in the iGB-21 cells as compared to iGB-4 cells (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Co-staining of SpiB protein with memory/naive B cell marker (CD38) and PC marker (CD138) revealed that SpiB<sup>high</sup> cells expressed higher levels of CD38 and little CD138, whereas SpiB<sup>low</sup> cells expressed lower CD38 and were mostly CD138<sup>+</sup> (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1E</bold>
</xref>). Among the iGB-4 cells, IgG1<sup>+</sup> cells were largely SpiB<sup>+</sup> CD38<sup>high</sup> CD138<sup>&#x2013;</sup>, whereas IgE<sup>+</sup> cells contained a substantial population of SpiB<sup>&#x2013;</sup> CD38<sup>low</sup> CD138<sup>+</sup> cells, which markedly increased in iGB-21 cells, either of IgG1<sup>+</sup> or IgE<sup>+</sup> (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;2D, E</bold>
</xref>). This result corresponded to the notion that IgE<sup>+</sup> B cells rapidly differentiate into PCs (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>) and IL-21 facilitates PC differentiation (<xref ref-type="bibr" rid="B7">7</xref>). These results suggest that SpiB may have a function to suppress PC differentiation while inducing the phenotype of B<sub>mem</sub> cells.</p>
</sec>
<sec id="s4_2">
<label>3.2</label>
<title>SpiB suppresses PC differentiation while inducing the expression of Bach2 <italic>in vitro</italic>
</title>
<p>To better understand the function of SpiB in B cell differentiation, we performed retroviral overexpression or knockdown of SpiB in iGB cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). Overexpression of SpiB resulted in the decrease, while knockdown of SpiB resulted in the increase, of the proportion of CD138<sup>+</sup> cells in both IgE<sup>&#x2013;</sup> (mostly IgG1<sup>+</sup>) and IgE<sup>+</sup> fractions of iGB-4 and iGB-21 cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3A</bold>
</xref>). PC differentiation is known to be induced by a transcription factor Blimp1 which is coded by the gene <italic>Prdm1</italic> (<xref ref-type="bibr" rid="B28">28</xref>). To further elucidate the mechanism of SpiB function, we analyzed the expression of <italic>Prdm1</italic> gene by using iGB cells derived from Blimp1-reporter (Blimp1-GFP) mice. Overexpression of SpiB resulted in the decrease, whereas knockdown of SpiB resulted in the increase, of the proportion of Blimp1 GFP<sup>+</sup> cells within IgE<sup>+</sup>, IgM<sup>+</sup> and IgE<sup>&#x2013;</sup> IgM<sup>&#x2013;</sup> (mostly IgG1<sup>+</sup>) B cells in iGB-4 and iGB-21 cells (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2C</bold>
</xref>). These results suggest the function of SpiB to suppress Blimp1 expression at a transcription level and thus PC differentiation.</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>SpiB suppresses PC differentiation and <italic>Blimp1</italic> expression while upregulates <italic>Bach2</italic> expression <italic>in vitro.</italic> <bold>(A)</bold> Experimental protocol for retroviral overexpression and knockdown of SpiB in iGB cells. Spleen B cells were cultured on 40LB feeder cells with IL-4 for 5 days (IGB-4), to which the overexpression or knockdown retroviral vectors were introduced on day 2, then followed by the culture with IL-21 for 3- 5 days (iGB-21). <bold>(B)</bold> FCM analysis of CD138 and IgE expression on SpiB-overexpressing (left) or SpiB-knockdown (right) IGB-4 and iGB-21 cells. <bold>(C)</bold> FCM analysis of Blimp1-GFP expression in SpiB-overexpressing (left) or SpiB-knockdown (right) IGB-4 and iGB-21 cells. IgE<sup>+</sup>, IgM<sup>+</sup> and IgE<sup>-</sup> IgM<sup>-</sup> (mostly IgG1<sup>+</sup>) populations were gated on iGB-4 and iGB-21 cells (top panels) and the expression of GFP in each population (bottom) were analyzed by FCM (bottom). <bold>(D, E)</bold> qRT-PCR analysis of mRNA expression of B cell-related genes in SpiB-overexpressng <bold>(D)</bold> and SpiB-knockdown <bold>(E)</bold> Blimp1-KO iGB-4 cells. *p &lt; 0.05, **p &lt; 0.01, ****p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g002.tif"/>
</fig>
<p>We further analyzed the mRNA expression levels of B-cell-related genes in the iGB-4 cells over-expressing SpiB and confirmed that the expression of <italic>Prdm1</italic> was suppressed by SpiB (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Of note, SpiB overexpression resulted in upregulation of the expression of <italic>Bach2</italic>, <italic>Pax5</italic>, and <italic>Bcl6</italic>, which encode transcription factors known to reciprocally suppress the expression of Blimp1 (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B29">29</xref>&#x2013;<xref ref-type="bibr" rid="B31">31</xref>) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;3B</bold>
</xref>). Blimp1 is known to suppress several B cell-related genes to positively regulate PC differentiation (<xref ref-type="bibr" rid="B32">32</xref>&#x2013;<xref ref-type="bibr" rid="B34">34</xref>). To clarify whether the SpiB-mediated upregulation of <italic>Bach2</italic>, <italic>Pax5</italic>, and <italic>Bcl6</italic> is independent of Blimp1, we used B cells from B-cell-specific Blimp1-deficient mice (Blimp1<sup>f/f</sup> CD19-cre; here called Blimp1-KO mice) for iGB cell culture. Overexpression of SpiB in the Blimp1-KO iGB-4 cells resulted in an increase of the expression of <italic>Bach2</italic>, <italic>Pax5</italic>, and <italic>Bcl6</italic>, whereas knockdown of SpiB resulted in the opposite outcome (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2D, E</bold>
</xref>). These results suggest that SpiB functions to suppress the expression of <italic>Blimp1</italic> and independently induce <italic>Bach2</italic>, <italic>Pax5</italic>, and <italic>Bcl6</italic> in B cells.</p>
</sec>
<sec id="s4_3">
<label>3.3</label>
<title>SpiB facilitates B<sub>mem</sub> cell maintenance in mice</title>
<p>The above results indicating that SpiB suppresses the expression of Blimp1 while inducing the expression of Bach2, suggesting that SpiB functions to generate or maintain B<sub>mem</sub> cells. To address this possibility, we applied our system in which iGB-4 cells differentiate to memory-like B (iMB) cells in the recipient mice (<xref ref-type="bibr" rid="B7">7</xref>). We retrovirally overexpressed or knocked down SpiB in iGB-4 cells and transferred these cells to irradiated mice respectively to generate iMB cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3A</bold>
</xref>). SpiB overexpression resulted in an increase in the frequency of the iMB cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3B</bold>
</xref>). On the contrary, SpiB knockdown resulted in the reduced frequency of the iMB cells (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>). These data indicated that SpiB promoted the generation or maintenance of iMB cells in a dose-dependent manner. These results strongly suggest that SpiB is a factor that regulates the generation or maintenance of B<sub>mem</sub> cells.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>SpiB is critical for B<sub>mem</sub> cell generation from iGB cells <italic>in vivo.</italic> <bold>(A)</bold> Experimental protocol for the generation of iMB cells from gene-transduced iGB-4 cells. iGB-4 cells derived from Ly5.1 congenic C57BL/6 (B6) mice were transduced with retroviral vectors expressing SpiB or shSpiB, or empty vectors as a control (cont.). These iGB-4 cells on day 5 were adaptively transferred to irradiated Ly5.2 congenic B6 mice. Spleen cells were analyzed 4 weeks later (for SpiB overexpression) or 2 weeks later (for SpiB knockdown) by FCM. <bold>(B, C)</bold> Frequencies of CD19<sup>+</sup> Ly5.1<sup>+</sup> iMB cells in the spleens of the recipient mice. A representative FCM data (left) and the frequencies among lymphocytes (right) [<bold>(B)</bold>: n = 6; <bold>(C)</bold>: n = 3]. *p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g003.tif"/>
</fig>
<p>To confirm this, we next analyzed the generation of B<sub>mem</sub> cells from SpiB-deficient B cells. Since SpiB null-knockout mice were previously reported to have defective GCs (<xref ref-type="bibr" rid="B15">15</xref>), we analyzed SpiB-floxed (<italic>SpiB</italic>
<sup>f/f</sup>) mice (see Materials and Methods 2.2) crossed with C&#x3b3;1-cre mice expressing cre recombinase only in B cells class-switched to IgG1 (<xref ref-type="bibr" rid="B20">20</xref>) (here called &#x2018;SpiB cKO&#x2019; mice). <italic>SpiB</italic>
<sup>+/+</sup> C&#x3b3;1-cre (called &#x2018;SpiB WT&#x2019;) mice were used as controls. The deletion of SpiB was confirmed in IgG1<sup>+</sup> B cells in the immunized mice and in iGB cells (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figures&#xa0;4A&#x2013;E</bold>
</xref>). We first examined the iMB cell generation from SpiB cKO iGB-4 cells <italic>in vivo</italic>. As expected from the result of SpiB-knockdown experiments (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3C</bold>
</xref>), very few IgG1<sup>+</sup> iMB cells were generated from SpiB cKO iGB-4 cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Long-lived B<sub>mem</sub> cells and memory antibody response are defective in SpiB cKO mice. <bold>(A)</bold> Frequencies of CD19<sup>+</sup> Ly5.1<sup>+</sup> (total iMB) cells and CD19<sup>+</sup> Ly5.1<sup>+</sup> IgG1<sup>+</sup> iMB cells in the spleens of the recipient mice transferred with iGB-4 cells derived from SpiB WT or SpiB cKO mouse B cells 4 weeks earlier, analyzed by FCM. A representative FCM data (left) and the frequencies among lymphocytes (right) (N =3). <bold>(B)</bold> A protocol of a mice immunization experiment. SpiB WT and SpiB cKO mice were intraperitoneally immunized with NP-CGG in alum and boosted with NP-GCC without alum to induce memory response at 66 days after the primary immunization. Spleen cells and blood were collected before immunization and at the indicated timepoints (spleen) and as indicated in <bold>(D)</bold> (blood). <bold>(C)</bold> Frequencies of NP<sup>+</sup> IgG1<sup>+</sup> or NP<sup>+</sup> IgG1<sup>-</sup>, total B, B<sub>mem</sub> and GC B cells in the spleens at the indicated time points after NP-CGG immunization in SpiB WT or SpiB cKO mice. Spleen cells were gated on B220<sup>+</sup> Ig&#x3ba;<sup>low</sup>, NP<sup>+</sup> IgG1<sup>+</sup> or NP<sup>+</sup> IgG1<sup>-</sup> cells before gating on B<sub>mem</sub> (GL7<sup>-</sup> CD38<sup>+</sup>) or GC B (GL7<sup>+</sup> CD38<sup>-</sup>) cells. A representative FCM data (left) and the frequencies among lymphocytes of three to six mice (right) are shown. <bold>(D)</bold> Concentrations of serum antibodies of total anti-NP-IgG1 (left) and high-affinity anti-NP-IgG1 (right) from SpiB WT or SpiB cKO mice primarily immunized with NP-CGG in alum and secondarily with NP-CGG alone on day 66. (n = 4) *p &lt; 0.05, **p &lt; 0.01.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g004.tif"/>
</fig>
<p>Next, we analyzed T cell-dependent (TD) immune response in the SpiB cKO mice by immunizing the mice with a typical TD antigen, NP-CGG, precipitated in alum. On day 7, 14, and 63 after the primary immunization, we analyzed GC B cells (GL7<sup>+</sup> CD38<sup>&#x2013;</sup>) and B<sub>mem</sub> cells (GL7<sup>&#x2013;</sup> CD38<sup>+</sup>) within NP-specific IgG1<sup>+</sup> and IgG1<sup>&#x2013;</sup> B cells by FCM (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>). The frequency and the absolute number of GC B and B<sub>mem</sub> cells did not significantly differ between SpiB WT and SpiB cKO mice in both NP<sup>+</sup> IgG1<sup>+</sup> and NP<sup>+</sup> IgG1<sup>&#x2013;</sup> B cell populations at 7- and 14-days post-immunization (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>). The concentration of blood anti-NP-IgG1 antibody was also similar between the two strains during the primary immune response (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). On day 63 post-immunization, when GC B cells almost disappeared, the number of B<sub>mem</sub> cells in the NP<sup>+</sup> IgG1<sup>+</sup> population, but not in the NP<sup>+</sup> IgG1<sup>&#x2013;</sup> population, was significantly reduced in SpiB cKO mice as compared to SpiB WT mice. We further analyzed the memory antibody response in these mice to determine the effect of the reduction of IgG1<sup>+</sup> B<sub>mem</sub> cells. After re-immunization of the mice with NP-CGG without adjuvants, the generation of serum anti-NP IgG1 antibodies was attenuated in SpiB cKO mice during the secondary immune response, which was highlighted when we detected only high-affinity antibodies that are mostly produced from B<sub>mem</sub> cells (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>). These results suggest that SpiB functions to maintain, rather than to induce, the antigen-specific B<sub>mem</sub> cells.</p>
</sec>
<sec id="s4_4">
<label>3.4</label>
<title>Regulation of B-cell-related genes by SpiB in GC and B<sub>mem</sub> cells</title>
<p>It is known that Bach2 functions as a suppressor for Blimp1 and regulates B<sub>mem</sub> cell differentiation (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B35">35</xref>). Our <italic>in-vitro</italic> analysis demonstrated that SpiB functions to suppress PC differentiation by suppressing Blimp1 expression while inducing the expression of Bach2 (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C&#x2013;E</bold>
</xref>). To elucidate the mechanism of SpiB function in B cells, we focused on the relationship of SpiB and Bach2. We first analyzed expression of SpiB and CD138 in the iGB-4 cells derived from splenic B cells of normal B6 (WT), Blimp1-KO, Bach2-KO, and Blimp1/Bach2-double KO mice by FCM. As expected, CD138<sup>+</sup> cells were induced in Bach2 KO iGB cells. However, the induction of CD138<sup>+</sup> cells was strongly suppressed in Blimp1/Bach2 double KO iGB-4 cells irrespective of their BCR isotype, indicating that Bach2 suppresses PC differentiation through Blimp1 suppression (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5A</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>SpiB suppresses PC differentiation independently of Bach2. <bold>(A)</bold> Expression of intracellular SpiB and cell-surface CD138 in SpiB WT, Blimp1-KO, Bach2-KO and Blimp1/Bach2 DKO iGB-4 cells analyzed by FCM. <bold>(B)</bold> mRNA expression of <italic>SpiB</italic>, <italic>Bach2</italic>, and <italic>Prdm1</italic> in SpiB WT and SpiB cKO iGB-4 cells analyzed by qRT-PCR. <bold>(C)</bold> FCM analysis of CD138 expression on Bach2-KO iGB-4 (left) and iGB-21 (right) cells transduced with mock-, Bach2-, SpiB-expressing retroviral vectors. <bold>(D)</bold> qRT-PCR analysis for mRNA expression of <italic>SpiB</italic>, <italic>Bach2</italic>, and <italic>Prdm1</italic> in IgG1<sup>+</sup> GC B and B<sub>mem</sub> cells from spleens of SpiB WT and SpiB cKO mice immunized with NP-CGG in alum 14 days earlier. *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g005.tif"/>
</fig>
<p>We next analyzed the expression of <italic>Bach2</italic> and <italic>Prdm1</italic> along with other B cell-related genes, such as <italic>Bcl6</italic>, <italic>Pax5</italic> and <italic>IRF4</italic>, in SpiB cKO and SpiB WT iGB-4 cells. SpiB-deficiency resulted in decrease of the expression of <italic>Bach2</italic> while increase of <italic>Prdm1</italic> and <italic>IRF4</italic> (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5B</bold>
</xref>). To verify the functional meaning of the SpiB-regulated expression of Bach2 and Blimp1, we retrovirally transduced SpiB and Bach2 into Bach2 KO iGB cells. The frequency of CD138<sup>+</sup> cells was strongly suppressed by SpiB overexpression in Bach-2 KO iGB-4 cells as observed by Bach2 reconstitution, and to a lesser extent in iGB-21 cells, indicating that SpiB can suppress PC differentiation independently of Bach2 (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). To further analyze the relation between Bach2 and SpiB <italic>in vivo</italic>, we sorted IgG1<sup>+</sup> GC and early B<sub>mem</sub> cells from SpiB WT and SpiB cKO mice 14 days after immunization with NP-CGG in alum, and analyzed the expression of <italic>Bach2</italic>, <italic>Prdm1</italic> and other B cell-related genes. In GC B cells, the expression of <italic>Bach2</italic> was decreased while that of <italic>Prdm1</italic> was increased by the SpiB-deficiency, with other B cell-related genes largely unaffected, resembling the result with iGB-4 cells. In the early B<sub>mem</sub> cells, however, the expression of <italic>Bach2</italic> and <italic>Prdm1</italic>, as well as of other genes, was not apparently affected by the SpiB-deficiency (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>; <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure&#xa0;5C</bold>
</xref>). These results indicate that SpiB upregulates <italic>Bach2</italic> expression and suppresses <italic>Blimp1</italic> expression and PC differentiation independently of Bach2 in GC B cells, which may render the longevity to the descendant B<sub>mem</sub> cells.</p>
</sec>
<sec id="s4_5">
<label>3.5</label>
<title>SpiB upregulates anti-apoptosis and autophagy genes and supports survival in B<sub>mem</sub> cells</title>
<p>Since the phenotype of SpiB cKO mice in the TD immune response was apparent only in the late B<sub>mem</sub> cells and their recall response, we suspected the function of SpiB to be more related to the maintenance of B<sub>mem</sub> cells rather than their generation. Previous studies have shown that autophagy is one of the mechanisms to inhibit apoptosis and to support the survival of memory T and B cells (<xref ref-type="bibr" rid="B36">36</xref>&#x2013;<xref ref-type="bibr" rid="B39">39</xref>). Therefore, we analyzed the expression levels of anti-apoptotic genes and autophagy genes in GC B and B<sub>mem</sub> cells sorted from SpiB cKO and SpiB WT mice 14 days after immunization with NP-CGG. As a result, SpiB cKO GC B cells express lower levels of anti-apoptotic genes (<italic>Bcl-X<sub>L</sub>
</italic>, <italic>Bcl2</italic>, <italic>Mcl1</italic>) and some autophagy genes (<italic>Atg5</italic>, <italic>Atg6</italic>, <italic>Atg7</italic>) as compared to SpiB WT GC B cells and the difference was more profound in B<sub>mem</sub> cells, except for <italic>Bcl2</italic> (<xref ref-type="fig" rid="f6">
<bold>Figures&#xa0;6A, B</bold>
</xref>).</p>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>SpiB-deficient GC B and B<sub>mem</sub> cells express lower levels of anti-apoptotic and autophagy genes and are more prone to die. <bold>(A, B)</bold> qRT-PCR analysis for mRNA expression of indicated anti-apoptotic genes (left) and autophagy genes (right) in IgG1<sup>+</sup> GC B cells <bold>(A)</bold> and IgG1<sup>+</sup> B<sub>mem</sub> cells <bold>(B)</bold> from spleens of SpiB WT and SpiB cKO mice immunized with NP-CGG in alum 14 days earlier. <bold>(C)</bold> FCM analysis for MitoSOX staining of the same cells as in <bold>(A, B)</bold> Cells were incubated for 0 or 9 hours in non-FCS medium before staining. Representative FCM data (left) and the frequencies of MitoSOX-positive cells (n = 3 or 4) (right). <bold>(D)</bold> FCM analysis for the expression of LC3B in the same cells as in <bold>(A, B)</bold> Representative FCM data (top) and mean fluorescence intensity (MFI) of the LC3B stained cells (bottom) are shown (n = 5). <bold>(E)</bold> Frequencies of dead cells in NP<sup>+</sup> IgG1<sup>+</sup> CD38<sup>+</sup> B<sub>mem</sub> cells from spleens of SpiB WT and SpiB cKO mice immunized with NP-CGG in alum 14 days earlier. Percentages of the dead cells detected microscopically following Trypan Blue staining after 9 hours&#x2019; culture in non-FCS medium as compared to those before the culture (n = 5). *p &lt; 0.05, **p &lt; 0.01, ***p &lt; 0.001, ****p &lt; 0.0001.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fimmu-14-1250719-g006.tif"/>
</fig>
<p>Autophagy is known to be necessary for the clearance of dysfunctional mitochondria that produce mitochondrial reactive oxygen species (mROS) (<xref ref-type="bibr" rid="B40">40</xref>) which is one of the factors to induce apoptosis (<xref ref-type="bibr" rid="B41">41</xref>). Given the almost undetectable levels of the autophagy genes, <italic>Atg5</italic>, <italic>Atg6</italic>, <italic>Atg7</italic>, in SpiB cKO B<sub>mem</sub> cells, we assessed mROS production in GC B and B<sub>mem</sub> cells sorted from immunized SpiB WT and SpiB cKO mice by staining them with MitoSox and analyzing by FCM. MitosSox positive cell population was small and similar between SpiB WT and SpiB cKO GC B and B<sub>mem</sub> cells before culture (0&#xa0;h), but the frequency of MitoSox-positive cells increased after 9 hours&#x2019; culture more abundantly in SpiB cKO GC B and B<sub>mem</sub> cells than SpiB WT ones (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6C</bold>
</xref>). We next addressed autophagy activity in SpiB cKO GC B and B<sub>mem</sub> cells by evaluating the expression of a known autophagy marker LC3B (<xref ref-type="bibr" rid="B42">42</xref>&#x2013;<xref ref-type="bibr" rid="B44">44</xref>). When compared with those from SpiB WT mice, GC B and B<sub>mem</sub> cells from SpiB cKO mice showed reduced expression of LC3B, indicating lower activity of autophagy in the absence of SpiB in these cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6D</bold>
</xref>). Finally, we found that IgG1<sup>+</sup> B<sub>mem</sub> cells in the immunized SpiB cKO mice contained more dead cells than those in the immunized SpiB WT mice after 9-hour incubation in the plain medium (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6E</bold>
</xref>). Taken together, these results indicate that the lack of SpiB in GC B and B<sub>mem</sub> cells results in reduction of gene expression and activity for autophagy, leading to the accumulation of mROS and increased susceptibility to apoptosis.</p>
</sec>
</sec>
<sec id="s5" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>Having been faced with the global pandemic of SARS-CoV-2, fundamental regulation of B<sub>mem</sub> cell survival after vaccination is gathering more attention than ever. How B<sub>mem</sub> cells behave after the re-exposure to the antigen has recently becoming clearer. For example, B<sub>mem</sub> cell subsets characterized by BCR isotypes as well as the expression of CD80/PD-L2 were shown to behave differently in the recall response in both human and mice (<xref ref-type="bibr" rid="B45">45</xref>, <xref ref-type="bibr" rid="B46">46</xref>). However, mechanisms of B<sub>mem</sub> cell generation and maintenance are largely unknown. While it was reported that Bach2 is required for the generation of B<sub>mem</sub> cells, Bach2 was expressed in majority of GC B cells as well as naive B cells (<xref ref-type="bibr" rid="B6">6</xref>). Thus, the specific function of Bach2 in the B<sub>mem</sub> cell development remains obscure.</p>
<p>To tackle this difficult problem, we used our original <italic>in-vitro</italic>-induced GC B (iGB) cell culture and induced memory B (iMB) cell system for the functional analysis of transcription factors by retroviral overexpression and knockdown. In this study, we focused on transcription factors whose expression levels were higher in the B<sub>mem</sub>-like iMB cells than naive B cells, and identified SpiB that acts as a key factor for the maintenance of B<sub>mem</sub> cells. Overexpression of SpiB suppressed differentiation of CD138<sup>+</sup> PCs by inhibiting the expression of Blimp1, while knockdown of SpiB facilitated the PC differentiation, in the iGB cells <italic>in vitro</italic>. We further assessed <italic>in-vivo</italic> development of iMB cells from these manipulated iGB cells. Overexpression of SpiB in iGB cells increased the frequency of iMB cells, while knockdown of SpiB decreased it. These results indicated the role of SpiB in B<sub>mem</sub> cell generation and/or maintenance well before generation and analysis of SpiB KO mice, demonstrating the iGB-iMB system as a powerful and easier tool to investigate the molecular mechanisms for GC B cell differentiation <italic>in vivo</italic>. In accord with this result, the number of long-lived B<sub>mem</sub> cells was significantly reduced in SpiB cKO mice, consistent with the supposed role of SpiB in B<sub>mem</sub> cell maintenance.</p>
<p>The mechanism of the maintenance of B<sub>mem</sub> still remains unclear. It has been supposed that anti-apoptotic protein Bcl2 promotes survival of B<sub>mem</sub> cells mainly from the results showing increased number of B<sub>mem</sub> cells in Bcl2-transgenic mice. However, it has been reported that transgenic Bcl2 inhibits apoptosis and promotes proliferation of GC B cells, resulting in an increased number of B<sub>mem</sub> cells (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>). Therefore, the contribution of Bcl2 to B<sub>mem</sub> cell survival will remain unclear until the B<sub>mem</sub>-cell-specific Bcl2-knockout mice become available. Our data demonstrated that the expression of Bcl2 gene was not reduced in the SpiB-deficient B<sub>mem</sub> cells being affected in their long-liveness, instead the expression of BclxL gene was almost abrogated. Although BclxL was reported to be dispensable for development of GC B and B<sub>mem</sub> cells (<xref ref-type="bibr" rid="B49">49</xref>), BclxL may play a redundant role in collaboration with other factors that are regulated by SpiB.</p>
<p>It has been reported that autophagy protein Atg7 regulates B<sub>mem</sub> cell survival (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B50">50</xref>, <xref ref-type="bibr" rid="B51">51</xref>) and that the Atg7-dependent autophagy is independent of Bcl2-mediated anti-apoptosis pathway (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B51">51</xref>). We found that the expression of autophagy genes, <italic>Atg5, Atg6</italic>, and <italic>Atg7</italic> was markedly reduced in the SpiB-deficient B<sub>mem</sub> cells, which exhibited a phenotype with diminished autophagy activity, increased mitochondrial ROS, and augmented cell death. Thus, attenuated mitophagy resulting in the over-production of ROS, together with the abolished BclxL expression, may render B<sub>mem</sub> cells prone to die earlier in SpiB-KO mice.</p>
<p>Direct binding and regulation by SpiB of its possible target genes in GC B cells remain to be determined, for example, by ChIP-Seq analysis. Regarding this, it was reported that PU.1 and SpiB share some binding targets in B cell lymphoma, suggesting that they may work together as co-factors to regulate target genes in GC B cells (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). In mice lacking both PU.1 and SpiB in B cells, the number of follicular B cells was decreased and the GC response was abrogated, while these defects were ameliorated in mice lacking PU.1 alone in B cells, and not apparent in mice lacking SpiB alone (<xref ref-type="bibr" rid="B53">53</xref>). This result suggests that PU.1 is mainly responsible for the generation of follicular and GC B cells, but SpiB compensates this function to some extent when PU.1 is absent. Thus, SpiB does not seem to be responsible for these functions but for the maintenance of B<sub>mem</sub> cells under normal conditions.</p>
<p>In conclusion, we found that SpiB plays a critical role in the maintenance of B<sub>mem</sub> cells. Further studies are needed to fully understand the mechanisms underlying SpiB-mediated B<sub>mem</sub> cell maintenance and the potential therapeutic implications of this finding. Investigating of the detailed function of SpiB and its relationship with genes involved in metabolism, will provide a better understanding of the regulation of B<sub>mem</sub> cells, ultimately leading to the development of vaccines that can generate longer-lasting humoral memory.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by Animal Care and Use Committee of Tokyo University of Science. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s8" sec-type="author-contributions">
<title>Author contributions</title>
<p>DK supervised and funded the project. SH designed and performed the experiments. TKo and HT contributed to conducting the experiments. KH, IS, YF-O and TKa were involved in methodology, investigation, and writing of the original draft, on SpiB cKO mice. SH and DK wrote the manuscript. All authors contributed to the article and approved the submitted version.</p>
</sec>
</body>
<back>
<sec id="s9" sec-type="funding-information">
<title>Funding</title>
<p>This work was supported by Grant-in-Aid for Scientific Research on Innovative Areas from MEXT, Japan (to DK, JP25118730).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>We thank Dr. Alexander Tarakhovsky (Rockefeller University) for <italic>Blimp1<sup>f/f</sup>
</italic> mice, Dr. Mitinori Saitou (Kyoto University) for Blimp1-GFP mice, Drs. Akihiko Muto and Kazuhiko Igarashi (Tohoku University) for <italic>Bach2<sup>-/-</sup>
</italic> mice, and Dr. Klaus Rajewsky (Max-Delbr&#xfc;ck Center for Molecular Medicine) for C&#x3b3;1-cre and CD19-cre mice. We thank Evan Rossignol for proofreading.</p>
</ack>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fimmu.2023.1250719/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fimmu.2023.1250719/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laidlaw</surname> <given-names>BJ</given-names>
</name>
<name>
<surname>Cyster</surname> <given-names>JG</given-names>
</name>
</person-group>. <article-title>Transcriptional regulation of memory B cell differentiation</article-title>. <source>Nat Rev Immunol</source> (<year>2021</year>) <volume>21</volume>(<issue>4</issue>):<page-range>209&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41577-020-00446-2</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname> <given-names>C</given-names>
</name>
<name>
<surname>Brink</surname> <given-names>R</given-names>
</name>
</person-group>. <article-title>The unique biology of germinal center B cells</article-title>. <source>Immunity</source> (<year>2021</year>) <volume>54</volume>(<issue>8</issue>):<page-range>1652&#x2013;64</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2021.07.015</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoue</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shinnakasu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Kurosaki</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Generation of high quality memory B cells</article-title>. <source>Front Immunol</source> (<year>2021</year>) <volume>12</volume>:<elocation-id>825813</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2021.825813</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitamura</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Mechanisms for the regulation of memory B-cell recall responses in mice</article-title>. <source>Int Immunol</source> (<year>2021</year>) <volume>33</volume>(<issue>12</issue>):<page-range>791&#x2013;6</page-range>. doi: <pub-id pub-id-type="doi">10.1093/intimm/dxab042</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takatsuka</surname> <given-names>S</given-names>
</name>
<name>
<surname>Yamada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Haniuda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Saruwatari</surname> <given-names>H</given-names>
</name>
<name>
<surname>Ichihashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Renauld</surname> <given-names>JC</given-names>
</name>
<etal/>
</person-group>. <article-title>IL-9 receptor signaling in memory B cells regulates humoral recall responses</article-title>. <source>Nat Immunol</source> (<year>2018</year>) <volume>19</volume>(<issue>9</issue>):<page-range>1025&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-018-0177-0</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shinnakasu</surname> <given-names>R</given-names>
</name>
<name>
<surname>Inoue</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kometani</surname> <given-names>K</given-names>
</name>
<name>
<surname>Moriyama</surname> <given-names>S</given-names>
</name>
<name>
<surname>Adachi</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Nakayama</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulated selection of germinal-center cells into the memory B cell compartment</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>7</issue>):<page-range>861&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3460</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nojima</surname> <given-names>T</given-names>
</name>
<name>
<surname>Haniuda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Moutai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Matsudaira</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mizokawa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Shiratori</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>
<italic>In-vitro</italic> derived germinal centre B cells differentially generate memory B or plasma cells in vivo</article-title>. <source>Nat Commun</source> (<year>2011</year>) <volume>2</volume>:<fpage>465</fpage>. doi: <pub-id pub-id-type="doi">10.1038/ncomms1475</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Ip</surname> <given-names>HS</given-names>
</name>
<name>
<surname>Cobb</surname> <given-names>BS</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Simon</surname> <given-names>MC</given-names>
</name>
</person-group>. <article-title>The Ets protein Spi-B is expressed exclusively in B cells and T cells during development</article-title>. <source>J Exp Med</source> (<year>1996</year>) <volume>184</volume>(<issue>1</issue>):<page-range>203&#x2013;14</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.184.1.203</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schotte</surname> <given-names>R</given-names>
</name>
<name>
<surname>Rissoan</surname> <given-names>MC</given-names>
</name>
<name>
<surname>Bendriss-Vermare</surname> <given-names>N</given-names>
</name>
<name>
<surname>Bridon</surname> <given-names>JM</given-names>
</name>
<name>
<surname>Duhen</surname> <given-names>T</given-names>
</name>
<name>
<surname>Weijer</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>The transcription factor Spi-B is expressed in plasmacytoid DC precursors and inhibits T-, B-, and NK-cell development</article-title>. <source>Blood</source> (<year>2003</year>) <volume>101</volume>(<issue>3</issue>):<page-range>1015&#x2013;23</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2002-02-0438</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanaya</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hase</surname> <given-names>K</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>D</given-names>
</name>
<name>
<surname>Fukuda</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hoshino</surname> <given-names>K</given-names>
</name>
<name>
<surname>Sasaki</surname> <given-names>I</given-names>
</name>
<etal/>
</person-group>. <article-title>The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells</article-title>. <source>Nat Immunol</source> (<year>2012</year>) <volume>13</volume>(<issue>8</issue>):<page-range>729&#x2013;36</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.2352</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>DeKoter</surname> <given-names>RP</given-names>
</name>
<name>
<surname>Geadah</surname> <given-names>M</given-names>
</name>
<name>
<surname>Khoosal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Thillainadesan</surname> <given-names>G</given-names>
</name>
<name>
<surname>Torchia</surname> <given-names>J</given-names>
</name>
<etal/>
</person-group>. <article-title>Regulation of follicular B cell differentiation by the related E26 transformation-specific transcription factors PU.1, Spi-B, and Spi-C</article-title>. <source>J Immunol</source> (<year>2010</year>) <volume>185</volume>(<issue>12</issue>):<page-range>7374&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1001413</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Batista</surname> <given-names>CR</given-names>
</name>
<name>
<surname>Li</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>LS</given-names>
</name>
<name>
<surname>Solomon</surname> <given-names>LA</given-names>
</name>
<name>
<surname>DeKoter</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>PU.1 regulates ig light chain transcription and rearrangement in pre-B cells during B cell development</article-title>. <source>J Immunol</source> (<year>2017</year>) <volume>198</volume>(<issue>4</issue>):<page-range>1565&#x2013;74</page-range>.  doi:&#xa0;<pub-id pub-id-type="doi">10.4049/jimmunol.1601709</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garrett-Sinha</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Su</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kabak</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction</article-title>. <source>Immunity</source> (<year>1999</year>) <volume>10</volume>(<issue>4</issue>):<fpage>399</fpage>&#x2013;<lpage>408</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(00)80040-0</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Rao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ramirez-Bergeron</surname> <given-names>DL</given-names>
</name>
<name>
<surname>Garrett-Sinha</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Gerondakis</surname> <given-names>S</given-names>
</name>
<name>
<surname>Clark</surname> <given-names>MR</given-names>
</name>
<etal/>
</person-group>. <article-title>PU.1/Spi-B regulation of c-rel is essential for mature B cell survival</article-title>. <source>Immunity</source> (<year>2001</year>) <volume>15</volume>(<issue>4</issue>):<page-range>545&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s1074-7613(01)00219-9</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Su</surname> <given-names>GH</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>HM</given-names>
</name>
<name>
<surname>Muthusamy</surname> <given-names>N</given-names>
</name>
<name>
<surname>Garrett-Sinha</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Baunoch</surname> <given-names>D</given-names>
</name>
<name>
<surname>Tenen</surname> <given-names>DG</given-names>
</name>
<etal/>
</person-group>. <article-title>Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B</article-title>. <source>EMBO J</source> (<year>1997</year>) <volume>16</volume>(<issue>23</issue>):<page-range>7118&#x2013;29</page-range>. doi: <pub-id pub-id-type="doi">10.1093/emboj/16.23.7118</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laramee</surname> <given-names>AS</given-names>
</name>
<name>
<surname>Raczkowski</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shao</surname> <given-names>P</given-names>
</name>
<name>
<surname>Batista</surname> <given-names>C</given-names>
</name>
<name>
<surname>Shukla</surname> <given-names>D</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Opposing roles for the related ETS-family transcription factors Spi-B and Spi-C in regulating B cell differentiation and function</article-title>. <source>Front Immunol</source> (<year>2020</year>) <volume>11</volume>:<elocation-id>841</elocation-id>. doi: <pub-id pub-id-type="doi">10.3389/fimmu.2020.00841</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schmidlin</surname> <given-names>H</given-names>
</name>
<name>
<surname>Diehl</surname> <given-names>SA</given-names>
</name>
<name>
<surname>Nagasawa</surname> <given-names>M</given-names>
</name>
<name>
<surname>Scheeren</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Schotte</surname> <given-names>R</given-names>
</name>
<name>
<surname>Uittenbogaart</surname> <given-names>CH</given-names>
</name>
<etal/>
</person-group>. <article-title>Spi-B inhibits human plasma cell differentiation by repressing BLIMP1 and XBP-1 expression</article-title>. <source>Blood</source> (<year>2008</year>) <volume>112</volume>(<issue>5</issue>):<page-range>1804&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2008-01-136440</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ohinata</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Payer</surname> <given-names>B</given-names>
</name>
<name>
<surname>O'Carroll</surname> <given-names>D</given-names>
</name>
<name>
<surname>Ancelin</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ono</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Sano</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>Blimp1 is a critical determinant of the germ cell lineage in mice</article-title>. <source>Nature</source> (<year>2005</year>) <volume>436</volume>(<issue>7048</issue>):<page-range>207&#x2013;13</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature03813</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Muto</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tashiro</surname> <given-names>S</given-names>
</name>
<name>
<surname>Nakajima</surname> <given-names>O</given-names>
</name>
<name>
<surname>Hoshino</surname> <given-names>H</given-names>
</name>
<name>
<surname>Takahashi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Sakoda</surname> <given-names>E</given-names>
</name>
<etal/>
</person-group>. <article-title>The transcriptional programme of antibody class switching involves the repressor Bach2</article-title>. <source>Nature</source> (<year>2004</year>) <volume>429</volume>(<issue>6991</issue>):<page-range>566&#x2013;71</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nature02596</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casola</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cattoretti</surname> <given-names>G</given-names>
</name>
<name>
<surname>Uyttersprot</surname> <given-names>N</given-names>
</name>
<name>
<surname>Koralov</surname> <given-names>SB</given-names>
</name>
<name>
<surname>Seagal</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hao</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Tracking germinal center B cells expressing germ-line immunoglobulin gamma1 transcripts by conditional gene targeting</article-title>. <source>Proc Natl Acad Sci U S A.</source> (<year>2006</year>) <volume>103</volume>(<issue>19</issue>):<page-range>7396&#x2013;401</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0602353103</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rickert</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Rajewsky</surname> <given-names>K</given-names>
</name>
<name>
<surname>Roes</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice</article-title>. <source>Nature</source> (<year>1995</year>) <volume>376</volume>(<issue>6538</issue>):<page-range>352&#x2013;5</page-range>. doi: <pub-id pub-id-type="doi">10.1038/376352a0</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koike</surname> <given-names>T</given-names>
</name>
<name>
<surname>Harada</surname> <given-names>K</given-names>
</name>
<name>
<surname>Horiuchi</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kitamura</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>The quantity of CD40 signaling determines the differentiation of B cells into functionally distinct memory cell subsets</article-title>. <source>Elife</source> (<year>2019</year>) <volume>8</volume>. doi: <pub-id pub-id-type="doi">10.7554/eLife.44245</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartholdy</surname> <given-names>B</given-names>
</name>
<name>
<surname>Du Roure</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bordon</surname> <given-names>A</given-names>
</name>
<name>
<surname>Emslie</surname> <given-names>D</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Matthias</surname> <given-names>P</given-names>
</name>
</person-group>. <article-title>The Ets factor Spi-B is a direct critical target of the coactivator OBF-1</article-title>. <source>Proc Natl Acad Sci U S A.</source> (<year>2006</year>) <volume>103</volume>(<issue>31</issue>):<page-range>11665&#x2013;70</page-range>. doi: <pub-id pub-id-type="doi">10.1073/pnas.0509430103</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Song</surname> <given-names>S</given-names>
</name>
<name>
<surname>Cao</surname> <given-names>C</given-names>
</name>
<name>
<surname>Choukrallah</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Tang</surname> <given-names>F</given-names>
</name>
<name>
<surname>Christofori</surname> <given-names>G</given-names>
</name>
<name>
<surname>Kohler</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>OBF1 and Oct factors control the germinal center transcriptional program</article-title>. <source>Blood</source> (<year>2021</year>) <volume>137</volume>(<issue>21</issue>):<page-range>2920&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood.2020010175</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hurt</surname> <given-names>EM</given-names>
</name>
<name>
<surname>Rosenwald</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program</article-title>. <source>Immunity</source> (<year>2002</year>) <volume>17</volume>(<issue>1</issue>):<fpage>51</fpage>&#x2013;<lpage>62</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(02)00335-7</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Sullivan</surname> <given-names>BM</given-names>
</name>
<name>
<surname>Allen</surname> <given-names>CD</given-names>
</name>
</person-group>. <article-title>Fluorescent in <italic>vivo</italic> detection reveals that IgE(+) B cells are restrained by an intrinsic cell fate predisposition</article-title>. <source>Immunity</source> (<year>2012</year>) <volume>36</volume>(<issue>5</issue>):<page-range>857&#x2013;72</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2012.02.009</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haniuda</surname> <given-names>K</given-names>
</name>
<name>
<surname>Fukao</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kodama</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hasegawa</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kitamura</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>Autonomous membrane IgE signaling prevents IgE-memory formation</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>9</issue>):<page-range>1109&#x2013;17</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3508</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shapiro-Shelef</surname> <given-names>M</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>KI</given-names>
</name>
<name>
<surname>McHeyzer-Williams</surname> <given-names>LJ</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>J</given-names>
</name>
<name>
<surname>McHeyzer-Williams</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Calame</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Blimp-1 is required for the formation of immunoglobulin secreting plasma cells and pre-plasma memory B cells</article-title>. <source>Immunity</source> (<year>2003</year>) <volume>19</volume>(<issue>4</issue>):<page-range>607&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1016/S1074-7613(03)00267-X</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delogu</surname> <given-names>A</given-names>
</name>
<name>
<surname>Schebesta</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>Q</given-names>
</name>
<name>
<surname>Aschenbrenner</surname> <given-names>K</given-names>
</name>
<name>
<surname>Perlot</surname> <given-names>T</given-names>
</name>
<name>
<surname>Busslinger</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells</article-title>. <source>Immunity</source> (<year>2006</year>) <volume>24</volume>(<issue>3</issue>):<page-range>269&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2006.01.012</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Minnich</surname> <given-names>M</given-names>
</name>
<name>
<surname>Tagoh</surname> <given-names>H</given-names>
</name>
<name>
<surname>Bonelt</surname> <given-names>P</given-names>
</name>
<name>
<surname>Axelsson</surname> <given-names>E</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>M</given-names>
</name>
<name>
<surname>Cebolla</surname> <given-names>B</given-names>
</name>
<etal/>
</person-group>. <article-title>Multifunctional role of the transcription factor Blimp-1 in coordinating plasma cell differentiation</article-title>. <source>Nat Immunol</source> (<year>2016</year>) <volume>17</volume>(<issue>3</issue>):<page-range>331&#x2013;43</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3349</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vasanwala</surname> <given-names>FH</given-names>
</name>
<name>
<surname>Kusam</surname> <given-names>S</given-names>
</name>
<name>
<surname>Toney</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Dent</surname> <given-names>AL</given-names>
</name>
</person-group>. <article-title>Repression of AP-1 function: a mechanism for the regulation of Blimp-1 expression and B lymphocyte differentiation by the B cell lymphoma-6 protooncogene</article-title>. <source>J Immunol</source> (<year>2002</year>) <volume>169</volume>(<issue>4</issue>):<page-range>1922&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.169.4.1922</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>KI</given-names>
</name>
<name>
<surname>Angelin-Duclos</surname> <given-names>C</given-names>
</name>
<name>
<surname>Kuo</surname> <given-names>TC</given-names>
</name>
<name>
<surname>Calame</surname> <given-names>K</given-names>
</name>
</person-group>. <article-title>Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells</article-title>. <source>Mol Cell Biol</source> (<year>2002</year>) <volume>22</volume>(<issue>13</issue>):<page-range>4771&#x2013;80</page-range>. doi: <pub-id pub-id-type="doi">10.1128/MCB.22.13.4771-4780.2002</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochiai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Maienschein-Cline</surname> <given-names>M</given-names>
</name>
<name>
<surname>Simonetti</surname> <given-names>G</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Rosenthal</surname> <given-names>R</given-names>
</name>
<name>
<surname>Brink</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Transcriptional regulation of germinal center B and plasma cell fates by dynamica control of IRF4</article-title>. <source>Immunity</source> (<year>2013</year>) <volume>38</volume>(<issue>5</issue>):<page-range>918&#x2013;29</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.immuni.2013.04.009</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nutt</surname> <given-names>SL</given-names>
</name>
<name>
<surname>Taubenheim</surname> <given-names>N</given-names>
</name>
<name>
<surname>Hasbold</surname> <given-names>J</given-names>
</name>
<name>
<surname>Corcoran</surname> <given-names>LM</given-names>
</name>
<name>
<surname>Hodgkin</surname> <given-names>PD</given-names>
</name>
</person-group>. <article-title>The genetic network controlling plasma cell differentiation</article-title>. <source>Semin Immunol</source> (<year>2011</year>) <volume>23</volume>(<issue>5</issue>):<page-range>341&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.smim.2011.08.010</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ochiai</surname> <given-names>K</given-names>
</name>
<name>
<surname>Katoh</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ikura</surname> <given-names>T</given-names>
</name>
<name>
<surname>Hoshikawa</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Noda</surname> <given-names>T</given-names>
</name>
<name>
<surname>Karasuyama</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Plasmacytic transcription factor Blimp-1 is repressed by Bach2 in B cells</article-title>. <source>J Biol Chem</source> (<year>2006</year>) <volume>281</volume>(<issue>50</issue>):<page-range>38226&#x2013;34</page-range>. doi: <pub-id pub-id-type="doi">10.1074/jbc.M607592200</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname> <given-names>X</given-names>
</name>
<name>
<surname>Araki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Li</surname> <given-names>S</given-names>
</name>
<name>
<surname>Han</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Ye</surname> <given-names>L</given-names>
</name>
<name>
<surname>Tan</surname> <given-names>WG</given-names>
</name>
<etal/>
</person-group>. <article-title>Autophagy is essential for effector CD8(+) T cell survival and memory formation</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>12</issue>):<page-range>1152&#x2013;61</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.3025</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murera</surname> <given-names>D</given-names>
</name>
<name>
<surname>Arbogast</surname> <given-names>F</given-names>
</name>
<name>
<surname>Arnold</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bouis</surname> <given-names>D</given-names>
</name>
<name>
<surname>Muller</surname> <given-names>S</given-names>
</name>
<name>
<surname>Gros</surname> <given-names>F</given-names>
</name>
</person-group>. <article-title>CD4 T cell autophagy is integral to memory maintenance</article-title>. <source>Sci Rep</source> (<year>2018</year>) <volume>8</volume>(<issue>1</issue>):<fpage>5951</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-23993-0</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fujii</surname> <given-names>H</given-names>
</name>
<name>
<surname>Shirai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Saito</surname> <given-names>S</given-names>
</name>
<name>
<surname>Ishii</surname> <given-names>T</given-names>
</name>
<name>
<surname>Harigae</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Autophagy plays a protective role as an anti-oxidant system in human T cells and represents a novel strategy for induction of T-cell apoptosis</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>8</issue>):<page-range>2508&#x2013;20</page-range>. doi: <pub-id pub-id-type="doi">10.1002/eji.201344248</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kodali</surname> <given-names>S</given-names>
</name>
<name>
<surname>Li</surname> <given-names>M</given-names>
</name>
<name>
<surname>Budai</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Protection of quiescence and longevity of IgG memory B cells by mitochondrial autophagy</article-title>. <source>J Immunol</source> (<year>2022</year>) <volume>208</volume>(<issue>5</issue>):<page-range>1085&#x2013;98</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.2100969</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Green</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Galluzzi</surname> <given-names>L</given-names>
</name>
<name>
<surname>Kroemer</surname> <given-names>G</given-names>
</name>
</person-group>. <article-title>Mitochondria and the autophagy-inflammation-cell death axis in organismal aging</article-title>. <source>Science</source> (<year>2011</year>) <volume>333</volume>(<issue>6046</issue>):<page-range>1109&#x2013;12</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1201940</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gottlieb</surname> <given-names>E</given-names>
</name>
<name>
<surname>Vander Heiden</surname> <given-names>MG</given-names>
</name>
<name>
<surname>Thompson</surname> <given-names>CB</given-names>
</name>
</person-group>. <article-title>Bcl-x(L) prevents the initial decrease in mitochondrial membrane potential and subsequent reactive oxygen species production during tumor necrosis factor alpha-induced apoptosis</article-title>. <source>Mol Cell Biol</source> (<year>2000</year>) <volume>20</volume>(<issue>15</issue>):<page-range>5680&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1128/MCB.20.15.5680-5689.2000</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tanida</surname> <given-names>I</given-names>
</name>
<name>
<surname>Minematsu-Ikeguchi</surname> <given-names>N</given-names>
</name>
<name>
<surname>Ueno</surname> <given-names>T</given-names>
</name>
<name>
<surname>Kominami</surname> <given-names>E</given-names>
</name>
</person-group>. <article-title>Lysosomal turnover, but not a cellular level, of endogenous LC3 is a marker for autophagy</article-title>. <source>Autophagy</source> (<year>2005</year>) <volume>1</volume>(<issue>2</issue>):<fpage>84</fpage>&#x2013;<lpage>91</lpage>. doi: <pub-id pub-id-type="doi">10.4161/auto.1.2.1697</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Watanabe</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ichinose</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hayashizaki</surname> <given-names>K</given-names>
</name>
<name>
<surname>Tsubata</surname> <given-names>T</given-names>
</name>
</person-group>. <article-title>Induction of autophagy by B cell antigen receptor stimulation and its inhibition by costimulation</article-title>. <source>Biochem Biophys Res Commun</source> (<year>2008</year>) <volume>374</volume>(<issue>2</issue>):<page-range>274&#x2013;81</page-range>. doi: <pub-id pub-id-type="doi">10.1016/j.bbrc.2008.07.013</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>He</surname> <given-names>C</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>C</given-names>
</name>
<name>
<surname>He</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
<name>
<surname>Ladds</surname> <given-names>M</given-names>
</name>
<etal/>
</person-group>. <article-title>CD36 and LC3B initiated autophagy in B cells regulates the humoral immune response</article-title>. <source>Autophagy</source> (<year>2021</year>) <volume>17</volume>(<issue>11</issue>):<page-range>3577&#x2013;91</page-range>. doi: <pub-id pub-id-type="doi">10.1080/15548627.2021.1885183</pub-id>
</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zuccarino-Catania</surname> <given-names>GV</given-names>
</name>
<name>
<surname>Sadanand</surname> <given-names>S</given-names>
</name>
<name>
<surname>Weisel</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Tomayko</surname> <given-names>MM</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kleinstein</surname> <given-names>SH</given-names>
</name>
<etal/>
</person-group>. <article-title>CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype</article-title>. <source>Nat Immunol</source> (<year>2014</year>) <volume>15</volume>(<issue>7</issue>):<page-range>631&#x2013;7</page-range>. doi: <pub-id pub-id-type="doi">10.1038/ni.2914</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weisel</surname> <given-names>NM</given-names>
</name>
<name>
<surname>Joachim</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Smita</surname> <given-names>S</given-names>
</name>
<name>
<surname>Callahan</surname> <given-names>D</given-names>
</name>
<name>
<surname>Elsner</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Conter</surname> <given-names>LJ</given-names>
</name>
<etal/>
</person-group>. <article-title>Surface phenotypes of naive and memory B cells in mouse and human tissues</article-title>. <source>Nat Immunol</source> (<year>2022</year>) <volume>23</volume>(<issue>1</issue>):<page-range>135&#x2013;45</page-range>. doi: <pub-id pub-id-type="doi">10.1038/s41590-021-01078-x</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname> <given-names>KG</given-names>
</name>
<name>
<surname>Light</surname> <given-names>A</given-names>
</name>
<name>
<surname>O'Reilly</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Ang</surname> <given-names>SM</given-names>
</name>
<name>
<surname>Strasser</surname> <given-names>A</given-names>
</name>
<name>
<surname>Tarlinton</surname> <given-names>D</given-names>
</name>
</person-group>. <article-title>bcl-2 transgene expression inhibits apoptosis in the germinal center and reveals differences in the selection of memory B cells and bone marrow antibody-forming cells</article-title>. <source>J Exp Med</source> (<year>2000</year>) <volume>191</volume>(<issue>3</issue>):<page-range>475&#x2013;84</page-range>. doi: <pub-id pub-id-type="doi">10.1084/jem.191.3.475</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egle</surname> <given-names>A</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>AW</given-names>
</name>
<name>
<surname>Bath</surname> <given-names>ML</given-names>
</name>
<name>
<surname>O'Reilly</surname> <given-names>L</given-names>
</name>
<name>
<surname>Cory</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>VavP-Bcl2 transgenic mice develop follicular lymphoma preceded by germinal center hyperplasia</article-title>. <source>Blood</source> (<year>2004</year>) <volume>103</volume>(<issue>6</issue>):<page-range>2276&#x2013;83</page-range>. doi: <pub-id pub-id-type="doi">10.1182/blood-2003-07-2469</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vikstrom</surname> <given-names>I</given-names>
</name>
<name>
<surname>Carotta</surname> <given-names>S</given-names>
</name>
<name>
<surname>Luthje</surname> <given-names>K</given-names>
</name>
<name>
<surname>Peperzak</surname> <given-names>V</given-names>
</name>
<name>
<surname>Jost</surname> <given-names>PJ</given-names>
</name>
<name>
<surname>Glaser</surname> <given-names>S</given-names>
</name>
<etal/>
</person-group>. <article-title>Mcl-1 is essential for germinal center formation and B cell memory</article-title>. <source>Science</source> (<year>2010</year>) <volume>330</volume>(<issue>6007</issue>):<page-range>1095&#x2013;9</page-range>. doi: <pub-id pub-id-type="doi">10.1126/science.1191793</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Shi</surname> <given-names>X</given-names>
</name>
<name>
<surname>Gilbert</surname> <given-names>BE</given-names>
</name>
<etal/>
</person-group>. <article-title>Essential role for autophagy in the maintenance of immunological memory against influenza infection</article-title>. <source>Nat Med</source> (<year>2014</year>) <volume>20</volume>(<issue>5</issue>):<page-range>503&#x2013;10</page-range>. doi: <pub-id pub-id-type="doi">10.1038/nm.3521</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kodali</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jang</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kuai</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Requirement for autophagy in the long-term persistence but not initial formation of memory B cells</article-title>. <source>J Immunol</source> (<year>2015</year>) <volume>194</volume>(<issue>6</issue>):<page-range>2607&#x2013;15</page-range>. doi: <pub-id pub-id-type="doi">10.4049/jimmunol.1403001</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solomon</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Li</surname> <given-names>SK</given-names>
</name>
<name>
<surname>Piskorz</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>LS</given-names>
</name>
<name>
<surname>DeKoter</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Genome-wide comparison of PU.1 and Spi-B binding sites in a mouse B lymphoma cell line</article-title>. <source>BMC Genomics</source> (<year>2015</year>) <volume>16</volume>(<issue>1</issue>):<fpage>76</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12864-015-1303-0</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Willis</surname> <given-names>SN</given-names>
</name>
<name>
<surname>Tellier</surname> <given-names>J</given-names>
</name>
<name>
<surname>Liao</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Trezise</surname> <given-names>S</given-names>
</name>
<name>
<surname>Light</surname> <given-names>A</given-names>
</name>
<name>
<surname>O'Donnell</surname> <given-names>K</given-names>
</name>
<etal/>
</person-group>. <article-title>Environmental sensing by mature B cells is controlled by the transcription factors PU.1 and SpiB</article-title>. <source>Nat Commun</source> (<year>2017</year>) <volume>8</volume>(<issue>1</issue>):<fpage>1426</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41467-017-01605-1</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>